Alendronate and indapamide alone or in combination in the management of hypercalciuria associated with osteoporosis: A randomized controlled trial of two drugs and three treatments

Nephrology Dialysis Transplantation

Volumn 24, Issue 5, 2009, Pages 1472-1477

  Giusti, Andrea ^a   Barone, Antonella ^a   Pioli, Giulio ^b   Girasole, Giuseppe ^c   Siccardi, Vincenzo ^c   Palummeri, Ernesto ^a   Bianchi, Gerolamo ^c  

^a GALLIERA HOSPITAL   (Italy)

^b Geriatric Unit   (Italy)

^c La Colletta Hospital ^*  (Italy)

Author keywords

Alendronate; Idiopathic hypercalciuria; Indapamide; Osteoporosis; Treatment

Indexed keywords

ALENDRONIC ACID; ALKALINE PHOSPHATASE BONE ISOENZYME; CALCIUM; INDAPAMIDE; PARATHYROID HORMONE; PHOSPHATE;

ADULT; AGED; ARTICLE; BONE DENSITY; CALCIUM BLOOD LEVEL; CALCIUM INTAKE; CALCIUM URINE LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DRUG WITHDRAWAL; FEMALE; FEMUR NECK; FLUID INTAKE; HIP; HUMAN; HYPERCALCIURIA; ITALY; LUMBAR SPINE; MAJOR CLINICAL STUDY; MORNING DOSAGE; OSTEOLYSIS; PARATHYROID HORMONE BLOOD LEVEL; PHOSPHATE BLOOD LEVEL; POSTMENOPAUSE; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; TREATMENT RESPONSE; UNSPECIFIED SIDE EFFECT;

AGED; ALENDRONATE; BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; CALCIUM; DIURETICS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPERCALCIURIA; INDAPAMIDE; MIDDLE AGED; OSTEOPOROSIS, POSTMENOPAUSAL;

EID: 65249179435     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn690     Document Type: Article

References (28)

1. Liebman SE, Taylor JG, Bushinsky DA. Idiopathic hypercalciuria. Curr Rheumatol Rep 2006; 8: 70-75
2. Hodgkinson A, Pyrah LN. The urinary excretion of calcium and inorganic phosphate in 344 patients with calcium stone of renal origin. Br J Surg 1958; 46: 10-18
3. Pak CY, Ohata M, Lawrence EC et al. The hypercalciurias. Causes, parathyroid functions, and diagnostic criteria. J Clin Invest 1974; 54: 387-400
4. Pacifici R, Rothstein M, Rifas L et al. Increased monocyte interleukin-1 activity and decreased vertebral bone density in patients with fasting idiopathic hypercalciuria. J Clin Endocrinol Metab 1990; 71: 138-145
5. Weisinger JR, Alonzo E, Carlini RG et al. Bone disease in hypercalciuria: a new form of osteodystrophy? Nephrol Dial Transplant 1998; 13(Suppl 3): 88-90
6. Heilberg IP, Weisinger JR. Bone disease in idiopathic hypercalciuria. Curr Opin Nephrol Hypertens 2006; 15: 394-402
7. Pacifici R. Idiopathic hypercalciuria and osteoporosis - distinct clinical manifestations of increased cytokine-induced bone resorption? J Clin Endocrinol Metab 1997; 82: 29-31
8. Borghi L, Meschi T, Guerra A et al. Vertebral mineral content in diet-dependent and diet-independent hypercalciuria. J Urol 1991; 146: 1334-1338
9. Giannini S, Nobile M, Dalle Carbonare L et al. Hypercalciuria is a common and important finding in postmenopausal women with osteoporosis. Eur J Endocrinol 2003; 149: 209-213
10. Vezzoli G, Rubinacci A, Bianchin C et al. Intestinal calcium absorption is associated with bone mass in stone-forming women with idiopathic hypercalciuria. Am J Kidney Dis 2003; 42: 1177-1183
11. Heller HJ, Zerwekh JE, Gottschalk FA et al. Reduced bone formation and relatively increased bone resorption in absorptive hypercalciuria. Kidney Int 2007; 71: 808-815
12. Melton LJ III, Crowson CS, Khosla S et al. Fracture risk among patients with urolithiasis: a population-based cohort study. Kidney Int 1998; 53: 459-464
13. Pak CY, Heller HJ, Pearle MS et al. Prevention of stone formation and bone loss in absorptive hypercalciuria by combined dietary and pharmacological interventions. J Urol 2003; 169: 465-469
14. Legroux-Gerot I, Catanzariti L, Marchandise X et al. Bone mineral density changes in hypercalciuretic osteoporotic men treated with thiazide diuretics. Joint Bone Spine 2004; 71: 51-55
15. Ceylan K, Topal C, Erkoc R et al. Effect of indapamide on urinary calcium excretion in patients with and without urinary stone disease. Ann Pharmacother 2005; 39: 1034-1038
16. Steiniche T, Mosekilde L, Christensen MS et al. Histomorphometric analysis of bone in idiopathic hypercalciuria before and after treatment with thiazide. APMIS 1989; 97: 302-308
17. Borghi L, Meschi T, Guerra A et al. Randomized prospective study of a nonthiazide diuretic, indapamide, in preventing calcium stone recurrences. J Cardiovasc Pharmacol 1993; 22(Suppl 6): S78-S86
18. Lemieux G. Treatment of idiopathic hypercalciuria with indapamide. CMAJ 1986; 135: 119-121
19. Martins MC, Meyers AM, Whalley NA et al.Indapamide (Natrilix): the agent of choice in the treatment of recurrent renal calculi associated with idiopathic hypercalciuria. Br J Urol 1996; 78: 176-180
20. Russell RG, Watts NB, Ebetino FH et al. Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy. Osteoporos Int 2008; 19: 733-759
21. Bushinsky DA, Neumann KJ, Asplin J et al. Alendronate decreases urine calcium and supersaturation in genetic hypercalciuric rats. Kidney Int 1999; 55: 234-243
22. Heilberg IP, Martini LA, Teixeira SH et al. Effect of etidronate treatment on bone mass of male nephrolithiasis patients with idiopathic hypercalciuria and osteopenia. Nephron 1998; 79: 430-437
23. Weisinger JR, Alonzo E, Machado C et al. Role of bones in the physiopathology of idiopathic hypercalciuria: effect of amino-bisphosphonate alendronate. Medicina (B Aires) 1997; 57(Suppl 1): 45-48
24. Angbrat M, Moller M. Questionnaire about calcium intake: can we trust the answers? Osteoporos Int 1999; 9: 220-225
25. Giusti A, Barone A, Razzano M et al. High prevalence of secondary hyperparathyroidism due to hypovitaminosis D in hospitalized elderly with and without hip fracture. J Endocrinol Invest 2006; 29: 809-813
26. Barone A, Giusti A, Pioli G et al. Secondary hyperparathyroidism due to hypovitaminosis D affects bone mineral density response to alendronate in elderly women with osteoporosis: a randomized controlled trial. J Am Geriatr Soc 2007; 55: 752-757
27. Pietschmann F, Breslau NA, Pak CYC. Reduced vertebral bone density in hypercalciuric nephrolithiasis. J Bone Miner Res 1992; 12: 1383-1388
28. Weisinger JR, Alonzo E, Bellorin-Font E et al. Possible role of cytokines on the bone mineral loss in idiopathic hypercalciuria. Kidney Int 1996; 49: 244-250